Log on / register
Feedback | Support | My details
Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression.
Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F
Breast Cancer Res 2005, 7:R788-95
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
Longatto-Filho A, Pinheiro C, Martinho O, Moreira MAR, Ribeiro LFJ, Queiroz GS, Schmitt FC, Baltazar F, Reis RM
BMC Cancer 2009, 9:212 (29 June 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

2.


Research article    
Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes
Bonifaci N, Berenguer A, Díez J, Reina O, Medina I, Dopazo J, Moreno V, Pujana MA
BMC Medical Genomics 2008, 1:62 (18 December 2008)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

3.


Commentary    
Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer
Leary AF, Sirohi B, Johnston SRD
Breast Cancer Research 2007, 9:112 (26 October 2007)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

4.


Primary research    
Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer
Taja-Chayeb L, Chavez-Blanco A, Martínez-Tlahuel J, González-Fierro A, Candelaria M, Chanona-Vilchis J, Robles E, Dueñas-Gonzalez A
Cancer Cell International 2006, 6:22 (2 October 2006)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]


This article is also cited by a further 2 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.